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Abstract
Background: UK policy direction for recipients of unemployment and sickness benefits is to support these people into 
employment by increasing 'into work' interventions. Although the main aim of associated interventions is to increase 
levels of employment, improved health is stated as a benefit, and a driver of these interventions. This is therefore a 
potentially important policy intervention with respect to health and health inequalities, and needs to be validated 
through rigorous impact evaluation.
We attempted to evaluate the Pathways Advisory Service intervention which aims to provide employment support for
Incapacity Benefit recipients, but encountered a number of challenges and barriers to evaluation. This paper explores
the issues that arose in designing a suitable evaluation of the Pathways Advisory Service.
Discussion: The main issues that arose were that characteristics of the intervention lead to difficulties in defining a 
suitable comparison group; and governance restrictions such as uncertainty regarding ethical consent processes and 
data sharing between agencies for research. Some of these challenges threatened fundamentally to limit the validity of 
any experimental or quasi-experimental evaluation we could design - restricting recruitment, data collection and 
identification of an appropriate comparison group. Although a cluster randomised controlled trial design was ethically 
justified to evaluate the Pathways Advisory Service, this was not possible because the intervention was already being 
widely implemented. However, this would not have solved other barriers to evaluation. There is no obvious method to 
perform a controlled evaluation for interventions where only a small proportion of those eligible are exposed. 
Improved communication between policymakers and researchers, clarification of data sharing protocols and improved 
guidelines for ethics committees are tangible ways which may reduce the current obstacles to this and other similar 
evaluations of policy interventions which tackle key determinants of health.
Summary: The evaluation of social interventions is hampered by more than their suitability to randomisation. Data 
sharing, participant identification and recruitment problems are common to randomised and non-randomised 
evaluation designs. These issues require further attention if we are to learn from current social policy.
Background
In 1999 the Acheson report highlighted the lack of evi-
dence around interventions to reduce health inequalities,
and recommended that all policies which impact on
determinants of health, such as income, housing and edu-
cation, be assessed for their health impact [1]. Ten years
later an inquiry by the House of Commons Health Com-
mittee (UK) into health inequalities found that Acheson's
recommendations had not generated the hoped-for evi-
dence. The Committee concluded that the lack of evi-
dence was "in large part due to inadequate evaluation of
the policies adopted" [2]. Interventions which affect
employment and income, such as tax and welfare poli-
cies, are an obvious possible means of improving the
health of the worst off and reducing health inequalities
[3-6]. Yet this appears to be a particularly neglected pol-
icy area with respect to knowledge of health impacts [7].
We set out to design an evaluation of the health impact
of the Pathways Advisory Service (PAS). In our attempt to
* Correspondence: kathryn@sphsu.mrc.ac.uk
1 MRC Social and Public Health Sciences Unit, 4 Lilybank Gardens, Glasgow, 
G12 8RZ, UK
Full list of author information is available at the end of the articleBioMed Central
© 2010 Skivington et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Com-
mons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduc-
tion in any medium, provided the original work is properly cited.
Skivington et al. BMC Public Health 2010, 10:254
http://www.biomedcentral.com/1471-2458/10/254
Page 2 of 8evaluate this aspect of the UK Government's Welfare to
Work programme for Incapacity Benefit (IB) recipients,
we struggled with the design because of the way in which
the policy was implemented, because of certain charac-
teristics of the intervention, and also because of addi-
tional pragmatic and governance restrictions. This paper
discusses these difficulties with a view to proposing solu-
tions that may facilitate such evaluations in the future.
Evaluation of these interventions is important given the
potentially large, but as yet unknown, health impact for
this population with poor health and relatively low
income [8]. The intervention discussed here is about
improving access to a service i.e. key elements of the
intervention are available elsewhere, but with low uptake
among target groups. Our experience is therefore rele-
vant for interventions that seek to address health inequal-
ities by improving access routes to services already
available, and to non health-focused interventions, that
may have health impacts.
Welfare to Work policy
The Welfare to Work programme in the UK seeks to
reduce the number of people claiming ill-health benefits
by moving them into employment. Policies aiming to
move people from worklessness into employment may be
regarded as important 'healthy public policy' interven-
tions as they have the potential to impact on health and
health inequalities. Although there is a positive relation-
ship between employment and health [9,10], the potential
for health benefits for welfare recipients moving into
employment is likely to be dependent on the type of work
obtained, the suitability to the job, job satisfaction, and
individual-level factors such as age and baseline health
status [6,10,11]. There is inconclusive evidence on the
work-health hypothesis for this population. Very few
studies show that a move from IB to employment has a
positive impact upon health. Waddell and Burton's recent
review of studies looking at the relationship between
work and health included a section of studies on work for
sick and disabled people [10]. The reported evidence
comprised expert opinions and policy documents; no
data from evaluations assessing the health impacts of the
interventions were reported. Reviewing social security
studies they reported that there may be a positive impact
on health for people who voluntarily move off benefits
(all types) and into work but this was not necessarily the
case for all groups and depended on the type of work [10].
It is likely that those moving from sickness benefit into
work may be employed in 'below average' standards of
work in terms of pay and conditions, satisfaction with
work etc. when they are competing with people in full
health for the same jobs [12]. In this case there is the risk
that a move into work may have a negative impact on
health, given the type of work obtained [10,13]. We
sought to improve evidence in this important policy area
for public health through the rigorous evaluation of one
of the UK's Welfare to Work policy initiatives which
focussed on facilitating IB recipients' return to work.
The intervention: Pathways Advisory Service
PAS was introduced in 2006; it is part of Pathways to
Work, the umbrella term for the group of welfare to work
initiatives aimed at people who are claiming out of work
ill health benefits. Although the main aim of associated
interventions is to increase levels of employment,
improved health is stated as a benefit, and a driver of
these interventions. PAS places employment and benefit
advisors into primary care centres (GP practices) as an
attempt to engage with IB recipients, utilising the
endorsement of the patient's own General Practitioner
(GP) and the context of a primary care setting to facilitate
discussions about returning to work. PAS is aimed at
improving access to services that are available to welfare
recipients elsewhere e.g. Jobcentre Plus, an agency of the
Government's Department for Work and Pensions. While
the service is available to all IB recipients in participating
GP practices, GPs use their discretion to refer patients to
PAS; referral criteria are broad and it is left to the GPs'
discretion to decide who is referred. Uptake is voluntary
and patients can also self-refer. About 20% of IB recipi-
ents in participating practices engage with the PAS inter-
vention (based on the average number of IB recipients
per GP practice, number of people referred to PAS, and
percentage of those who are referred who are on IB). It is
likely that those who are referred have relatively good
health and are closer to returning to the labour market
than non-referred IB recipients. An evaluation of the PAS
pilot programme, commissioned by the Department for
Work and Pensions (DWP), reported on processes e.g.
how people found out about PAS, how GPs engaged with
their patients, and what PAS meetings entailed; and
descriptive information on employment and benefit out-
comes. There was some discussion in the report of how a
move into work had impacted upon participants' health;
there were both positive and negative examples of how
work affected health for this group, and these were pre-
sented qualitatively [14]. The PAS programme was rolled
out before the results of the evaluation by Sainsbury et al
(2008) had been published, and before an evaluation of
health impacts could be planned. We set out to design an
evaluation of the health impact of PAS using self-
reported health measures, primary care records and rou-
tine hospital data collection.
Developing an impact evaluation of Pathways Advisory 
Service
In our attempt to evaluate PAS, a number of the charac-
teristics of the intervention that have been described
above, made it difficult for us to design a feasible evalua-
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likely impact on possible findings from an evaluation.
Study Designs Considered
A variety of study designs were considered for this evalu-
ation (see Table 2). We first looked into the possibility of
conducting a randomised controlled trial (RCT), the
obvious advantages being that this method would give the
most comparable intervention and comparison groups,
maximising internal validity. However, we believed the
individual RCT design would not have been feasible as
there was an infrastructure within practices to support
the intervention; there were several elements of the inter-
vention which required the entire GP practice to be
involved (e.g. the presence of the PAS advisor and the use
of advertising posters in the waiting room). It would also
require major commitment by GPs and GPs might not
recruit into the study those they thought were most in
need of the service. Additionally, it could make the inter-
vention unsustainable by reducing the referral rates to
PAS, as comparison patients would obviously not be
referred to the service. Because we were attempting to
design an evaluation after roll out of the service had com-
menced, a cluster randomised controlled trial was also
not possible. However even if it had been possible, it
would not have overcome the difficulty in defining a com-
parison group from the IB recipients at non-participating
GP practices, because only 20% of those eligible received
the intervention (Table 2).
The use of well conducted non-randomised study
designs has been advocated as an appropriate alternative
and can generate best available evidence where RCTs are
not feasible [15-17]. We attempted to design a robust,
quasi-experimental study: a non-randomised controlled
trial. To control for important confounding factors, we
considered it essential to have a comparison group in the
evaluation. A suitable comparison group would have to
be similar with respect to eligibility for the intervention
i.e. be in receipt of IB, and also similar in terms of health
status, length of time on benefits, employment history, as
Table 1: Important sources of bias independent of study design
Intervention characteristic Potential bias & other influences on effect estimates
Only a small proportion of the eligible IB population access 
the intervention
Selection
- it is very difficult to get a comparison group with the same characteristics 
as the intervention group
Intervention is to promote uptake of a service already 
available elsewhere (Jobcentre Plus)
Dilution - variation in exposure to the intervention across the study sample
- risk of contamination among comparison group
Intervention is targeted at socio-economically deprived 
population
Selection & Attrition
- less likely to participate in the study
- little incentive for comparison group to take part in research, withdrawals 
likely
GP practices volunteer to participate in the intervention Selection
- primary care service that is already motivated to promote service use 
among vulnerable group
Generalisability
- GP practices who volunteer to take part may differ from those who do not
Referral is opportunistic, referral criteria not well defined Selection
- referral decisions may vary within and between GPs
Number of potential sample within an intervention practice 
is unknown
Selection
- unknown number of eligible IB recipients will not be referred by GP
Identification and referral of eligible IB recipients initiates 
the intervention, before recruitment to the evaluation 
study
Recall
- Pre-intervention data reliant on medical notes and retrospective recall 
from IB recipient
Expected short term health effects likely to be small Study powered to detect small differences in health requires unfeasibly 
large population. Underpowered study may produce false result.
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ment/welfare services, such as other aspects of Pathways
to Work.
It is clear from Table 3 that evaluation of PAS is limited
by more than simply an inability to randomise. Each of
the options presented an attempt to include a comparison
group - which is preferable to a simple before and after
study. None of these three options provide a method for
an entirely unbiased comparison group, but option 3 has
the most potential. With option 2, there would have been
significant issues relating to determining the comparison
group by asking GPs in control practices to tell us who
they think would be eligible. These issues include: the
broad referral criteria would have made it difficult to ask
non-PAS practices to easily identify a possible compari-
son group (referral criteria is likely to vary between GP
practices, especially between those which have an estab-
lished service and GP practices which do not offer the
service at all); the fact that referral to PAS by GPs is often
opportunistic; and that it would require high levels of
input from GPs in non PAS practices. Instead, option 3
utilises two comparison groups: one from non-interven-
tion practices and the other from IB recipients who are
exposed to, but do not receive the intervention. This
would allow us to estimate possible differential character-
istics of those who engage with the service and those who
were exposed but who do not engage, as well as an esti-
mate of the effect of PAS.
Pragmatic and governance restrictions to the study
We initially discussed with the DWP to identify IB recipi-
ents from their records. The provision of these data was
not possible due to the implementation of a data transfer
ban following the high profile loss of sensitive personal
information by a number of Government departments.
Regardless of having these data we would still have faced
issues in evaluating PAS as it would have been necessary
to recruit GP practices to the study to determine who of
the IB recipients were exposed to PAS, and who engaged.
We therefore proposed to identify the target population
of IB recipients through GP electronic records which are
coded indicating a GP has completed a medical reference
for an IB claim. Although unlikely to be comprehensive in
their coverage of IB patients (we estimated from one
practice that around 70% of those claiming IB are
recorded on GP records), this approach would have pro-
vided a method of identifying potential study partici-
pants.
Table 2: Randomised controlled study options and key difficulties
Study design Disadvantages specific to 
study design
Key difficulty Outcome
Recruitment into study by GP 
followed by randomisation
Self-referral to PAS increases 
risk of contamination of 
comparison group
Service is available external to 
the study
Dilution bias
Underestimate of effect
GPs may refer those who they 
think most in need/most likely 
to benefit - rather than recruit 
to the study
Group being evaluated not 
representative of those using 
the service
This would half the flow of 
patients being referred to PAS
PAS may not be sustainable
Requires high levels of co-
operation from GP and PAS
Resource implications for GPs/
PAS
Cluster randomisation Need to identify IB recipients 
in comparison practices who 
would be eligible for referral 
to PAS: it is likely that this 
would only be around 20% of 
the total sample
Non-specific criteria for 
referral to service limits our 
capacity to identify an 
appropriate comparison 
group
Possible selection bias 
depending on ability to match 
controls
Cluster level differences need 
to be accounted for
Requires high levels of 
collaboration with policy 
makers well before 
implementation of pilot
Not possible given that PAS 
had been rolled out by the 
time of this evaluation
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tact details of potential participants. Those who had not
'opted-out' would be invited to participate in the study, at
which point we would obtain informed written consent
(Figure 1).
However, the local Research Ethics Committee (LREC)
and the MRC Regulatory Support Centre, advised that
opt-out permission to obtain contact details was not
compliant with the Data Protection Act (Figure 1). Com-
pliance with the Act required the primary care provider
to obtain written consent from patients to pass on their
contact details. This meant that written consent would
have to be obtained twice. For the comparison group this
would be first by postal invitation to allow the GP to pass
on contact details of potential participants to us, the
researchers, and a second time to participate in the study.
For the intervention group the PAS employment advisor
would ask for the first consent, and we would obtain sec-
ond written consent to include them in the study. We
believed that these processes would have resulted in very
low enrolment rates to the study, decreasing the genearal-
isabilty of the findings. Different recruitment options for
intervention and comparison group would increase the
likelihood of there being important differences between
the groups, as the comparison group would comprise IB
recipients who pro-actively volunteered to be part of a
study, thus increasing the likelihood that we make a Type
1 error. To date, the obstacles identified have prevented
us from undertaking an evaluation of the health effects of
PAS.
Table 3: Non-randomised controlled study options and key difficulties
Study design Disadvantages specific to 
study design
Key difficulty Outcome
Option 1: Intervention group: 
engagea with PAS
Comparison group: active 
exposure but no engagement 
with PASb
Systematic difference 
between intervention and 
comparison group. IB 
recipients who engage with 
PAS are likely to be healthier 
and closer to a return to work 
than those who are aware of 
PAS but are not referred (by 
GP or self).
Selection bias leading to 
overestimate of health effects
Option 2:
Intervention group: engage 
with PASa
Comparison group: not 
exposed to PAS d
Need to identify suitable 
comparison group with 
respect to eligibility for 
referral to PAS (only 20% of 
those in the comparison GP 
practices would be 
'comparable' to the 
intervention group)
How to determine suitable 
controls: option to ask GP in 
comparison practices to tell us 
who, in principle, they would 
refer to PAS. This requires a 
high level of involvement by 
GPs not offering PAS
Possible selection bias 
depending on ability to match 
controls
Cluster level influences need 
to be accounted for
Option 3:
Intervention group: engage 
with PASa
Comparison groups:
(1) Not exposed to PASd
(2) passive exposure to PASc
Need to identify suitable 
comparison group with 
respect to eligibility for 
referral to PAS (only 20% of 
those in the comparison GP 
practices would be 
'comparable' to the 
intervention group)
How to determine suitable 
controls (this will be aided by 
information from the group 
who are exposed but do not 
engage)
Possible selection bias 
depending on ability to match 
controls
Cluster level influences need 
to be accounted for
a Engagement with PAS: actually met with a PAS advisor
b Active exposure to PAS: GP refers patient to PAS but patient does not take up the referral
c Passive exposure to PAS: Registered patient with primary care practice participating in PAS service - may or may not be aware of PAS
d Not exposed to PAS: Registered patient with primary care practice not participating in PAS service
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A robust evaluation of the health impacts of PAS was
severely limited because of specific intervention charac-
teristics that made it difficult to define an appropriate
comparison group; because we had no control over its
roll-out; and because of pragmatic and governance
restrictions leading to constrained recruitment options. It
is worth considering how our experience can contribute
to knowledge about the future development of evaluation
methods. We believe that if the issues are not dealt with,
ability to generate evidence for important policy ques-
tions and for healthy public policy will remain limited.
Would an RCT design have been the answer?
It is acknowledged in the field of social interventions that
use of randomisation in evaluation design may not always
be possible, feasible [15,18,19], or appropriate given the
existing evidence of known effects [16,17]. In evaluating
PAS a cluster randomised trial was not feasible at this
stage, although it would have been justified with respect
to equipoise and the need for evidence (i.e. there is uncer-
tainty about the harms and benefits of the intervention
with respect to the intervention itself, employment, wel-
fare, income and health). The DWP are not averse to con-
sidering and undertaking RCTs, and are currently
participating in a large-scale RCT to evaluate the effec-
tiveness of an intervention for lone parents and the long-
term unemployed (although unfortunately not measuring
health effects) [20]. A similar design may have been plau-
sible to evaluate PAS, if it had been designed at the out-
set. However, a randomised design, developed at the
stage we became involved in the evaluation, would not
have been able to resolve other evaluation issues. Partici-
pants would still have to be identified through GP prac-
tices, thereby retaining the identification and recruitment
problems.
Moving towards an evaluation of the health effects on PAS
Employment and income are key determinants of health,
and even marginal changes in these factors may be
important for those living on low incomes and dependent
on welfare. It is frustrating that policymakers may be
unable to learn much about the effect on health of this
policy, and that such significant barriers are in place to
research with low risk to participants [8]. The challenges
that we have experienced in our evaluation design are
recurrent issues for researchers working in the field of
healthy public policy [17,21].
Rychetnik et al (2002) emphasised the need to evaluate,
and to use the best design appropriate to the question,
but to be clear about potential for bias [22]. In reality any
evaluation design can be limited by a number of factors.
Where multiple concurrent limitations are experienced
as we have described, this represents such a barrier, or
allows only evaluation that is likely to yield data so com-
promised, that there is likely to be a missed opportunity
to learn from new policy. We have identified multiple
(potential) sources of bias in the evaluation of PAS, which
leads us to contemplate whether the evaluation would be
worth doing at all. Our experience has highlighted issues
concerning control over implementation of the interven-
tion, identification and transfer of contact details of
potential participants, and the identification of a compar-
ison group. There is no straightforward solution to
resolve these issues, but possible routes to deal with them
may include: improving the working relationship between
researchers and policymakers to ensure social interven-
tions can be evaluated, and such evaluations contribute
appropriately to policy and practice; and clarification of
the Data Protection Act so that it is not left open to vary-
ing ethical and legal interpretations.
Closer working between policymakers and researchers
Closer working relationships between researchers and
policymakers may provide opportunities for researchers
to be involved in the early stages of the development of
interventions so that implementation and evaluation are
not considered as separate processes. The design of
appropriate evaluations would be facilitated if discussions
between policymakers and evaluators began in or before
what trialists refer to as phases I and II of an evaluation
[23]. Discussions at these early stages may facilitate use of
RCTs, but closer relationships between researchers and
policymakers remain important even when randomisa-
tion is not an option. Political culture may make policy-
makers want to be seen to be doing 'something' and press
ahead with roll out of interventions like PAS before think-
ing about evaluation, however as long-stated by the Brit-
Figure 1 Flowchart of proposed method of contact and consent 
of potential participants.
GP writes to potential participants, 
identified through medical records about 
Potential participants are given the 
chance to stop their contact details being 
passed on to the researchers (by 
returning the postage paid letter stating 
that they do not want to be contacted for 
this study)
GPs pass on contact details of those 
who did not state that they did not want 
contact details passed on, to the 
researchers
Researchers write to those they have 
contact details for, with more details 
about the study 
Local Research Ethics 
Committee required written 
opt-in consent for patient 
contact details to be 
passed on to researchers, 
GPs could send out only 1 
reminder letter to potential 
participants. 
Participants who give informed written 
consent at this stage are recruited to 
take part in the study 
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Select Committee report [2], it is important that policy
interventions should be evaluated. Closer working rela-
tionships thus have the potential to foster an evaluation
culture and an appreciation of the sometimes divergent
agendas of each group, and the complexity of 'evidence
based policy' given that 'evidence' may not only be based
on scientific research [25].
Data sharing protocols, legal and ethical interpretation of 
the Data Protection Act
There is ongoing debate about the interpretation of the
Data Protection Act with respect to research [26-28].
Guidance from the Information Commissioner's Office
(ICO) suggests that as a data controller, an organisation
should carefully consider which organisations they pass
information to and should ensure the external organisa-
tion can work in a secure way with an agreed written con-
tract [29]. In terms of organisations requesting
information about individuals from a data controller, the
ICO stipulates that the individuals should be informed of
disclosure, but it does not stipulate that written consent is
required to pass on contact details. The ICO goes on to
say that "there are a number of exemptions that allow dis-
closure in certain circumstances"; however it is unclear
what they are.
The Data Protection Act is open to interpretation, and
its interpretation would appear to vary between Research
Ethics Committees. There is a recent example of a
research study successfully gaining ethical approval to use
the 'opt out' contact approach that we originally proposed
for this study [30]. GP practices were recruited, potential
participants were identified and written to by their GP
and informed that their contact details would be passed
on to the researchers unless they replied stating that they
did not wish to take part. Researchers then contacted the
potential participants by telephone to recruit them to the
study.
In our study, the requirement to obtain written consent
for contact details to be passed to researchers, and again
at the point of study recruitment, was likely to lead to
decreased external validity. The recruitment rates
reported for other studies with 'opt in' consent before the
researchers can approach the potential participants is
between 8% and 34% [31-34]. Furthermore, response
rates among deprived populations, such as IB recipients,
are known to be low [35,36]. Given these facts, we were
sceptical about the ability to recruit a suitably representa-
tive sample, which led us to question the study's potential
value.
There is an obvious tension between the competing
interests of individual privacy and research [27,28,37,38].
We support the importance placed on individual privacy,
particularly for vulnerable groups such as IB recipients
who are already subject to considerable levels of surveil-
lance [39]. However, it can also be argued that continued
implementation of policies that are not properly evalu-
ated is unethical and permits potentially damaging inter-
ventions for vulnerable groups. Under present
arrangements, evaluation of interventions such as PAS
will be undermined by a recurring recruitment bias
caused by lack of an accessible sample frame, and evalua-
tions will be limited to internal evaluations or ecological-
level analyses of routine population data. There does not
appear to be standardised guidance for research ethics
committees on how to deal with requests such as ours
and it may be that more transparent guidance would
assist both researchers and ethics committees. If possible,
the guidance would take into account the need for
research and evaluation, whilst protecting participants'
rights. This would allow researchers to know what is con-
sidered ethical and also what procedures are required to
comply with legislation while designing a study. It is
important to bear in mind that ethical approval does not
mean that the research is legally in compliance with the
Data Protection Act; therefore development of standard
ethical guidelines which take this Act into account would
rely on clarification of the Act itself.
Summary
Health is a key consideration in Welfare to Work policies,
and it is widely cited as part of the rationale for returning
IB recipients to work, yet the relative benefits and harms
of PAS are unknown. There is a tension between the ethi-
cal requirements to protect the privacy of the individual
and the need to assess, through evaluation, the actual
impacts of the intervention. If the potential health effects
of these policies are to be realised it is essential that pro-
grammes designed to implement them can be rigorously
evaluated to determine both positive and negative effects.
Even where a RCT is appropriate, limitations to evalua-
tion may remain. Our experience is that evaluations, par-
ticularly after the intervention has been implemented,
remain limited by: a lack of suitable methods for evaluat-
ing interventions where only a small proportion of the eli-
gible population will engage; data sharing prohibitions;
privacy rules; and the interpretation of such rules by eth-
ics committees. These problems are not new but are
likely to continue to impede the development of evi-
dence-based policy until action is taken.
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